Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Amphetamine Aspartate

Client Email

Product

Amphetamine Aspartate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Amphetamine Aspartate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 10 USDMF, 11 NDC API, 4 Listed Suppliers, $ API Reference Price

10 API Suppliers
10 USDMF
11 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

PRICE INFORMATION

API Reference Price, API Imports

API Reference Price
API Imports

FINISHED DOSAGE FORMULATIONS

267 FDF Dossiers, 267 FDA Orange Book

267 FDF Dossiers
267 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG, CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG
CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG
CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG
CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG
CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG
CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 2 Rochem International Inc, 5 SPI Pharma, 8 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 11 Corel Pharma Chem, 2 DFE Pharma, 7 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 22 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 28 Controlled & Modified Release, 27 Direct Compression, 23 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Granulation, 14 Taste Masking, 12 Film Formers & Plasticizers, 12 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 11 Solubilizers, 9 Empty Capsules, 7 Chewable & Orodispersible Aids, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Parenteral, 2 Rheology Modifiers, 1 Topical, 1 Surfactant & Foaming Agents

54 Fillers, Diluents & Binders
53 Coating Systems & Additives
28 Controlled & Modified Release
27 Direct Compression
23 Thickeners and Stabilizers
16 Lubricants & Glidants
15 Granulation
14 Taste Masking
12 Film Formers & Plasticizers
12 Co-Processed Excipients
12 Disintegrants & Superdisintegrants
11 Solubilizers
9 Empty Capsules
7 Chewable & Orodispersible Aids
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
3 Parenteral
2 Rheology Modifiers
1 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 Annual Reports

5 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

8 US Patents

8 US Patents

$ API Ref.Price (USD/KG) : 2,479 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8TAKEDA PHARMS USA

filter Patent Number Reset all filters

8 All

01 48846100

02 49173857

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 4Y

02 4Blank

filter Expiration Date Reset all filters

8 All

01 42026-05-12

02 42029-08-24

Veranova Amphetamine Aspartate

Product Main Page

01

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-12

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 9173857

Drug Substance Claim :

Drug Product Claim :

Application Number : 22063

Patent Use Code : U-2025

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-12

Portfolio PDF

Product Web Link

Digital Content

02

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-12

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 9173857

Drug Substance Claim :

Drug Product Claim :

Application Number : 22063

Patent Use Code : U-2025

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-12

Portfolio PDF

Product Web Link

Digital Content

03

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-12

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 9173857

Drug Substance Claim :

Drug Product Claim :

Application Number : 22063

Patent Use Code : U-2025

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-12

Portfolio PDF

Product Web Link

Digital Content

04

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-12

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 9173857

Drug Substance Claim :

Drug Product Claim :

Application Number : 22063

Patent Use Code : U-2025

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-12

Portfolio PDF

Product Web Link

Digital Content

05

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-24

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 8846100

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22063

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-24

Portfolio PDF

Product Web Link

Digital Content

06

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-24

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 8846100

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22063

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-24

Portfolio PDF

Product Web Link

Digital Content

07

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-24

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 8846100

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22063

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-24

Portfolio PDF

Product Web Link

Digital Content

08

TAKEDA PHARMS USA

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Luxepack

Not Confirmed

TAKEDA PHARMS USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-24

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

US Patent Number : 8846100

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22063

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-24

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?